Zotarolimus
Zotarolimus (INN, codenamed ABT-578) is an immunosuppressant. It is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier. Coronary stents reduce early complications and improve late clinical outcomes in patients needing interventional cardiology.
| Catalog Number | 221877-54-9 |
| Alternative Name(s) | A-179578; A 179578; A179578; ABT-578; ABT578; ABT 578 |
| Molecular Formula | C52H79N5O12 |
| CAS# | 221877-54-9 |
| Purity | >98% |
| Inchi | InChI=1S/C52H79N5O12/c1-31-16-12-11-13-17-32(2)43(65-8)28-39-21-19-37(7)52(64,69-39)49(61)50(62)56-23-15-14-18-41(56)51(63)68-44(34(4)26-38-20-22-40(45(27-38)66-9)57-30-53-54-55-57)29-42(58)33(3)25-36(6)47(60)48(67-10)46(59)35(5)24-31/h11-13,16-17,25,30-31,33-35,37-41,43-45,47-48,60,64H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12-,32-17+,36-25+/t31-,33-,34-,35-,37-,38+,39+,40+,41+,43+,44+,45-,47-,48+,52-/m1/s1 |
| Inchi Key | CGTADGCBEXYWNE-GTTQIJKGSA-N |
| Size | Please inquire |
| Supplier Page | https://bio-fermen.bocsci.com/product/zotarolimus-cas-221877-54-9-102838.html |